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Abstract
Current avian influenza surveillance in poultry primarily targets subtypes of interest for the veterinary sector (H5, H7).
However, as virological and serological evidence suggest, surveillance of additional subtypes is important for public health
as well as for the poultry industry. Therefore, we developed a protein microarray enabling simultaneous identification of
antibodies directed against different HA-types of influenza A viruses in chickens. The assay successfully discriminated
negative from experimentally and naturally infected, seropositive chickens. Sensitivity and specificity depended on the cut-
off level used but ranged from 84.4% to 100% and 100%, respectively, for a cut off level of $1:40, showing minimal cross
reactivity. As this testing platform is also validated for the use in humans, it constitutes a surveillance tool that can be
applied in human-animal interface studies.
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Introduction
Avian influenza A viruses (AIV) belong to the family
Orthomyxoviridae and comprise eight gene segments consisting
of negative sense single-stranded RNA. The classification of AIV
into different subtypes is based on two surface structures,
hemagglutinin (HA) and neuraminidase (NA). To date, 18 distinct
HA-types and 11 NA-types are known of [1–3]. With the
exception of subtypes H17N10 and H18N11 of which RNA was
recently detected in bats, aquatic birds constitute reservoirs for
AIV, usually without showing signs of disease [1,2]. To date,
influenza A viruses have crossed the species barrier to humans,
swine, aquatic mammals, domestic poultry, birds of prey, horses,
mustelids, civets, felines and canines [4–6]. Several avian and
swine influenza viruses have zoonotic potential. While AIV
subtype A (H5N1) virus infections have had the largest economic
and public health impact so far, AIV with HA types 6, 7, 9 and 10
have also caused virologically confirmed human infection with
varying severity [4,6]. Until recently, human H7-infections have
been associated with mild symptoms in humans. However, since
early 2013, a newly emerging H7-subtype, A(H7N9), has formed
an exception by causing a more severe clinical picture and death in
about 36% of the recorded patients, possibly related to specific
host susceptibility factors [7,8]. Although the symptoms shown by
patients largely resembled infection with highly pathogenic (HP)
A(H5N1), the manifestation in poultry – the putative source of
direct human infection – is different [9,10]. Unlike HP A(H5N1)
viruses that cause severe illness and death in poultry, this novel
influenza A(H7N9) strain causes subclinical infection in poultry,
which allowed the virus to spread unnoticed over a large
geographic region in China [10]. Consequently, the general
population can be exposed to animals shedding this virus without
warning signs. Indeed, serological investigations in poultry workers
suggest more widespread infections in humans, possibly reflecting
mild or unapparent illness [11].
This example and additional serological evidence for human
infection with influenza viruses other than H5, H7, H9 and H10 –
including H4, H6 and H11 [12–14] – highlight the importance of
influenza monitoring at the human-animal interface, where
humans are currently sentinels for circulation of zoonotic viruses
[15,16]. Therefore, ideally, future serological studies evaluating
influenza viruses at the human-animal interface would include
these ‘‘neglected’’ subtypes.
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Given the ability of AIV H5 and H7 to mutate into HP forms
and the economic consequences associated with such infections, a
compulsory European Union-wide surveillance system was imple-
mented in 2005 [17]. In the Netherlands, serological monitoring is
more intensive than required by EU-regulations [18] and includes
screening of all poultry flocks at least once a year and high risk-
groups, e.g. free-range flocks every three months. In practice, a
representative number of farms and individuals per country are
pre-screened with an indirect or competitive enzyme-linked
immunosorbent assay (ELISA), identifying antibodies against
conserved regions (matrix or nucleoprotein) that all influenza
virus subtypes have in common [19]. Upon a positive pre-
screening result, the presence of H5- or H7-antibodies is
confirmed or ruled out by means of a hemagglutination inhibition
(HI)-assay, and flocks are tested for active virus circulation. While
this screening regimen meets the requirements for veterinary
surveillance, the characterization of non-H5 and -H7 but ELISA-
positive samples may be relevant for the poultry industry and for
public health.
Here, we describe the development and use of a protein
microarray (PA) that enables simultaneous screening for antibodies
to multiple influenza HA-types in poultry, using minute quantities
of serum (10 ml) that can be collected through routine veterinary
surveillance.
Materials and Methods
Sera
Three different serum sets (hereafter referred to as group 1–3)
were used to evaluate the performance of the PA for the use in
chicken:
1. Negative sera. Negative sera were obtained from different
sources. In total 38 chicken sera which tested negative by ELISA
(Idexx FlockChek AI, MultiS-Screen Ab Test Kit, Hoofddorp, the
Netherlands) were used:
1a) One serum pool of 52-week-old, specific pathogen free (SPF)
white layers (flock from GD AHS)
1b) Ten sera from 3-week-old, non-infected, non-vaccinated,
conventional Lohman Brown layers
1c) 27 sera from a commercial 6-week-old Ross broiler flock
(hereafter named ‘‘negative field chickens’’)
2. Consecutive serum samples from SPF chickens
experimentally infected with live field strains. Four
groups of 15 white SPF laying hens (GD AHS) were intratrache-
ally infected with live field strains (0.5 ml; ,106 EID50) belonging
to the subtypes H5N2, H6N2, H7N1 or H9N2 (Table 1) at 12
weeks of age. For the duration of the experiment infected chickens
were kept in isolators with twelve hours light per day, 20–25uC
and were given ad libitum access to food and water. Serum was
collected from the wing vein at day 7, 14 and 22 post infection
(p.i.) and seropositivity was confirmed by testing sera at one
dilution (1:8) by standard HI-assay, as is done routinely in the
animal health service. Therefore, data were available as positive/
negative results only.
3. Sera from outbreaks of avian influenza detected
during routine surveillance in the Netherlands. To
evaluate applicability of the test in the field, we analyzed samples
from four different laying hen flocks having undergone past
infection with low pathogenic (LP) AIV subtypes, hereafter named
‘‘naturally infected field chickens’’. All flocks were identified as
AIV exposed by ELISA-testing (Idexx FlockChek AI, MultiS-
Screen Ab Test Kit) of samples collected during routine
surveillance performed by the AHS. HI typing of sera, and/or
virus isolation and virus typing (CVI, Lelystad) confirmed initial
diagnosis. Samples were derived from two outbreaks caused by
subtype H6, both in flocks of 16-month-old, free-range brown
laying hens (outbreak 1: n= 10; outbreak 2: n = 7). In addition, ten
sera seropositive for LP H7N3 were obtained from 16-month-old,
free-range brown layers, and eight sera from an H9N2-outbreak in
19-month-old, brown laying hens housed in cages were screened.
Individual HI-titers were available for the H9- and one H6-
outbreak (outbreak 2). Sera of the remaining two outbreaks were
screened qualitatively at one dilution only (1:8).
Ethics statement
All experiments were approved by the Animal Experimental
Committee of the Faculty of Veterinary Medicine of the Utrecht
University or the Animal Welfare Committee (DEC) of the GD
Animal Health Service, Deventer, the Netherlands, in accordance
with the Dutch regulations on experimental animals.
Production of protein microarray-slides and sample
analysis
We used a modification of the technique that has been
described elsewhere [20]. In our study, 22 recombinant HA1-
proteins comprising representatives of 13 different subtypes
(Table 1) were printed onto 16-pad nitrocellulose slides as
described before [20]. Antigens were produced in human
embryonic kidney (HEK) cells, were purified by HIS-tag and
were delivered at a protein concentration of 1 mg/ml (see
manufacturer for details, Table 2). To determine the optimal
working concentration for the recombinant HA1-proteins used in
the PA, checkerboard titrations were performed for each protein
using four different dilutions (26, 46, 86, 166). When necessary,
proteins were concentrated using Amicon Ultra-0.5 mL Centrif-
ugal Filters for Protein Purification and Concentration according
to manufacturer’s instructions (Merck Millipore, Massachusetts,
USA) and checkerboard titrations were repeated thereafter.
Prior to testing, all sera were inactivated in a water bath at 56uC
for one hour. For serum analysis, four slides fixed in a FAST frame
slide holder (Whatman, Kent, UK) could be used simultaneously.
Each holder accommodated up to seven sera and one in house-
standard. Serum was titrated in two fold dilution series ranging
from 1:20 (10 ml of serum) to1:2560. Known negative sera were
tested in two-fold dilutions ranging from 1:20 to 1:160. An in
house-standard, comprising of a serum-pool of hyperimmunized
chickens infected with strains of subtypes H5, H6, H7 and H9 was
included in each test run. After serum incubation, bound
antibodies were visualized using a Cy5 AffiniPure rabbit anti-
chicken IgY Fc-fragment-specific conjugate (Jackson ImmunoR-
esearch, West Grove, USA) diluted in Blotto Blocking Buffer
(Thermo Fisher Scientific Inc., Rockford, MA, USA) and 0.1%
Surfact-Amps (Thermo Fisher Scientific Inc.) at a concentration of
1:1300. IgY represents the avian equivalent of mammalian IgG
[21].
Data analysis and statistics
Fluorescent signals were quantified and converted into titers as
described before [20]. The PA spanned a detection range of titers
from 1:20 to 1:2560. We calculated geometric mean titers (GMTs)
including 95% confidence intervals (CI) as well as homologous
versus heterologous GMT ratios of the validation data using
GraphPad Prism for Windows (Version 6.03, GraphPad Software
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Inc., California, USA). Log2-transformed median antibody titer
ratios of field chickens were plotted in R (R Foundation for
Statistical Computing, version 2.15). For consecutively collected
samples, seroconversion or a significant rise was defined as a $4
fold increase in antibody titer [22]. Correlations between the PA
and HI-test were calculated using a two-sided Spearman’s rank
correlation coefficient (r). A p-value of less than 0.05 was
considered statistically significant.
The overall antibody reactivity for all seropositive individuals
was visualized by means of a heat map, generated by applying
hierarchical clustering (pairwise correlation distance and Ward’s
method) to log-transformed titers. No cut off titer was applied to
the data. Bright red color indicates high titers whereas faint red
and white corresponds to low titers and no reactivity, respectively.
Amino acid (AA) sequence similarity of HA1s was determined
using a fast algorithm with pairwise alignment in Bionumerics
(version 6.6, Applied Maths).
Antigen stability and batch control
Antigen quality and stability between different batches was
tested using an in-house serum pool comprising HA-specific
polyclonal rabbit-antisera (Immune Technology Corp., New York,
USA) raised against all antigens included on the PA. Testing the
last slide from each batch of 25 slides showed that all antigens were
stable over time (data not shown). Prior experiments showed that
spotted PA slides containing recombinant influenza HA1-proteins
are stable for at least one year (unpublished data). Day-to-day
variation was controlled for by correcting all titers according to the
reactivity of the reference antigen H6.07 against the in house-
standard, as previously described [20].
Results
Four out of 38 negative sera (1.5%) – all four belonging to group
1c (negative field chickens) – showed minor low-level reactivity
with titers ranging between 21 and 30 against antigens H2.05 and
H12.91, respectively. All other samples tested negative for all
antigens (data not shown). These findings result in a specificity of
the PA of 94.6% to 100% at a cutoff titer of.1:20 across all
antigens, and of 100% when the cutoff was raised to $1:40 or
higher.
In contrast, all experimentally infected chickens (group 2)
seroconverted to the homologous antigens, although the kinetics of
response differed slightly. H5- and H6-infected animals were the
Table 1. Recombinant HA1-proteins used on the PA and viruses used for infection of chickens of group 2.
Proteins Subtype Strain Source
H1.18 H1N1 A/South Carolina/1/18 IT
H1.33 H1N1 A/WS/33 IT
H1.99 H1N1 A/New Caledonia/20/99 IT
H1.07 H1N1 A/Brisbane/59/2007 IT
H1.09 H1N1 A/California/6/2009 IT
H2.05 H2N2 A/Canada/720/05 IT
H3.68 H3N2 A/Aichi/2/1968 SB
H3.03 H3N2 A/Wyoming/3/03 IT
H4.02 H4N6 A/mallard/Ohio/657/2002 E
H5.97 H5N1 A/Hong Kong/156/97 (clade 0) IT
H5.06 H5N1 A/Turkey/15/2006 (clade 2.2) G
H5.02 H5N8 A/duck/NY/191255-59/2002 (LP) SB
H5.07 H5N3 A/duck/Hokkaido/167/2007 (LP) SB
H6.07 H6N1 A/northern shoveler/California/HKWF115/2007 SB
H7.03 H7N7 A/Chicken/Netherlands/1/03 IT
H8.79 H8N4 A/pintail duck/Alberta/114/1979 E
H9.99 H9N2 A/Guinea fowl/Hong Kong/WF10/99 IT
H9.07 H9N2 A/Chicken/Yunnan/YA114/2007 G
H11.02 H11N2 A/duck/Yangzhou/906/2002 IT
H12.91 H12N5 A/green-winged teal/ALB/199/1991 IT
H13.00 H13N8 A/black-headed gull/Netherlands/1/00 IT
H16.99 H16N3 A/black-headed gull/Sweden/5/99 IT
Infection Subtype Strain GISAID accession number
H5N2 A/chicken/Belgium/150/1999 EPI238402
H6N2 A/turkey/Massachusetts/3740/1965 EPI3187
H7N1 A/parrot/Northern Ireland/VF-73-67/73 EPI6514
H9N2 A/chicken/Saudi Arabia/SP02525/3AAV/2000 AHS
LP, low pathogenic; IT, Immune Technology Corp.; SB, Sino Biological Inc.; E, e-enzyme; G, Genscript; AHS, from Animal Health Service, Deventer, the Netherlands.
doi:10.1371/journal.pone.0108043.t001
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fastest to show 100% seroconversion at day 7 p.i. at a cut off of $
1:40 for at least one PA-antigen used, whereas for H7- and H9-
exposed animals complete seroconversion (100% of animals)
occurred at a later time point (Figure 1, Table 2). At day 22 p.i.
all animals showed a significant ($ 4-fold) titer increase. With
advancing antibody rise (at days 14 and 22 p.i.), sensitivities
further increased for antigens matching the infecting subtype. In
addition, we combined all serum collection time points to
investigate the ability of the PA to identify positive individuals in
different stages of antibody development and sensitivity remained
high (Table 2).
Interestingly, although H5-infected SPF chickens were inocu-
lated with a low-pathogenic H5-strain (Table 1), we observed the
strongest antibody response against H5.97, an antigen represent-
ing HP AIV clade 0 (Table 1, Figure 1). For the H9-infection
cohort, chickens showed mixed antibody reactivity against the two
H9-antigens, with half the individuals reacting stronger against
H9.99 and the other half displaying a higher titer against H9.07 at
day 7 p.i. One individual had an equally high titer for both
antigens at that time point. At day 14 and 22 p.i., reactivity profiles
shifted towards H9.07 in the majority of chickens, ten and nine out
of 15, respectively, displaying a higher titer against H9.07
compared to H9.99 (data not shown).
Cross-reactivity against heterologous antigens of
experimentally infected chickens (group 2)
In general, we observed some degree of heterogeneity in kinetics
and cross reactivity of antibody responses within all infection
groups (Figure 1). The ratio of homologous versus heterologous
GMTs of all sampling days combined ranged from 1.8 to 57.9 in
H5-, 19.1 to 161.1 in H6-, versus 12.8 to 27.4 for H7- and 4.6 to
13.3 in H9-infected individuals (Figures 1 and 2). The highest level
of cross reactivity was observed in H5-infected animals reacting
with the H2-antigen (GMT-ratio 1.8-4.2). Nevertheless, a clear
distinction between homologous and heterologous reactivity was
observed for the remaining antigens, with GMT ratios of .4 for
all other antigen combinations (Figures 1 and 2). Therefore, the
infecting strain could clearly be identified independent of the
cutoff level chosen (Figure 1). To minimize or dismiss the ‘‘noise’’
caused by cross-reacting antibodies, the application of a cutoff
level of $1:80 seems appropriate (Table 2, Figure 1).
Figure 1. Kinetics of serological responses of SPF chickens after intratracheal infection with live virus (group 2). Titles of each graph
indicate infection group. X-axes depict the day of serum collection post infection. Y-axes indicate geometric mean titers (GMT). Error bars represent
95% confidence intervals of the measurements. Note differences in log-scale. Heterologous reactions above the dotted line represent cross-reactive
responses with a titer higher than 1:40 or 1:80, respectively.
doi:10.1371/journal.pone.0108043.g001
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Serological profiles of naturally infected laying hens
(group 3)
Serum samples from naturally infected field chickens showed
similar discriminatory serological profiles compared with the data
from the validation experiments (Figure 3). In the analysis, we
combined the data of both H6-outbreaks. The PA correctly
identified 100% of the tested field chickens as positive up to a cut-
off titer of $1:80 (data not shown). Cross-reactivity was negligible
for H6- and H7-infected individuals and generally matched the
patterns observed in group 2 (Figure 3, light red, light green).
Among the field chickens naturally infected with H9, we observed
somewhat more cross reactivity (Figure 3 and 4). Nevertheless, the
infecting subtype was still evident by resulting in the highest
median log2-titer ratio (Figure 4).
Overall, the PA results showed good correlation with the HI-
assay. Spearman’s rank correlation coefficients showed strong,
significant associations between the HI-assay and PA-antigens
H9.07 (r=0.804, p= 0.021) and H6.07 (r=0.850, p = 0.029),
whereas a relatively strong but not statistically significant
association could be demonstrated between HI-data and PA-
antigen H9.99 (r=0.600, p= 0.121).
Discussion
Here we present a highly sensitive and specific multiplex-
screening tool to detect antibodies against different HA-types of
AIV in chickens. We show that the PA discriminates between
negative and experimentally infected, seropositive chickens. We
further demonstrate that our test can serve as a surveillance tool in
commercial field chicken flocks, by reliably identifying the
infecting subtypes in laying hens from free-range- and indoor
husbandry. An asset of the technique is that it requires a minute
quantity of serum (5–10 ml) to simultaneously screen for multiple
subtypes, whereas the HI-assay usually requires about the same
amount to detect antibodies against only one subtype [23]. This
characteristic is particularly advantageous when screening small
animal species of which only small volumes of sera are available.
Analysis of consecutive sera of SPF chickens infected with live
field strains of different AIV subtypes showed that the PA was able
Figure 2. Homologous versus heterologous geometric mean titer (GMT) ratios for different groups of experimentally infected
chickens (H5, H6, H7, H9) for all sampling days combined. A high homologous versus heterologous ratio in GMT indicates low cross-reacitivity
and vice versa. For instance, as for the H6-infection group the GMT against the homologous antigen H6.07 is 1668.8 and the GMT against the
heterologous antigen H7.03 is 10.4, the homologous vs. heterologous ratio is the highest (,161), implying that the level of cross-reactivity is lowest
for the H7-antigen in the H6-infection group. The dotted line demarkates a ratio of 4. Note differences in scale.
doi:10.1371/journal.pone.0108043.g002
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to quantify varying titer heights per sampling time point and
infection group. Such variation could either be due to differences
in immunogenicity of strains used for infection [24], infectious
dose [24,25], different chicken breeds or genetic lineages [24,26].
From a technical aspect, differing quality of antigens used on the
PA and distant relatedness of strains used for infection and the
assay antigen [27] could account for the differences in titer heights
between infection groups. As infectious dose and breed were the
same for all experimental infection cohorts and antigen quality was
checked prior to testing and monitored throughout the exper-
iment, these factors can be disregarded as a possible source of
variability.
Lee et al. [28] speculated that immunogenicity, and therefore
antibody titer heights, can depend on the protein itself and can
vary between strains of different subtypes in chickens immunized
with different DNA-vaccines. Failure to regularly update antigens
in HI-assay can result in a reduced ability to detect antibodies
against more recent field isolates [27] and it is unclear if this also
can be observed in our assay system. The strains used for the
infections of group 2 animals were closely related to the strains
from which antigens were produced, with the lowest level of AA-
identity for antigen H9.07 (94.4%) (Table 3). This lower AA-
identity in combination with individual variation could be a
possible explanation why H9.07 did not yet react at day 7 p.i. for
some experimentally infected chickens of group 2 (Figure 3, square
with black solid line). On the other hand, the lower AA-identity of
H9.07 did not seem to have a major influence, as this antigen
showed a higher GMT at day 14 and 22 p.i. in H9-infected
Figure 3. Heat map depicting serological patterns of naturally (n.i.) and experimentally infected (e.i.) chickens (H5, H6, H7, H9)
spanning all samplings days. Dendrograms reflect clustering based on similarity of serological profiles. Microarray antigens are depicted on the X-
axis. Different infection groups are color coded on the Y-axis according to the avian influenza virus subtype causing the infection. Rows represent
reaction profiles of individual chickens across the entire antigen panel. Columns represent the reactivity of all individuals against a specific antigen as
stated on the X-axis. Intensity of the red color is proportional to the log-titer height. Black dotted squares indicate missing antigens H5.07 (n = 6) and
H11.02 (n = 7) due to spotting failure. Black square with solid line indicates no biological reactivity against the H9.07 antigen. The clustering algorithm
automatically excluded negative sera.
doi:10.1371/journal.pone.0108043.g003
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chickens of group 2, compared to H9.99, which was 97.5% similar
to the infecting strain (Table 3). It is not known how AA
differences in HA1 translate to antigenic reactivity in the PA
system. Cattoli et al. [29] examined serological responses of drift
variants of H5 strains in chickens using HI- and microneutraliza-
tion assay. Of the 11 AA substitutions found in the HA1, the
researchers demonstrated that only five substitutions sufficed to
cause antigenic drift. These findings stress that a high AA sequence
similarity in the HA1 of two strains does not necessarily translate
into similar serological reactivity, if critical substitutions occur in
epitopes influencing antigenicity. Hence, AA sequence similarity is
not a good indicator for antigenicity and cross reactivity, so no
inferences about the compatibility between the viruses used for
infection and PA-antigens can be made.
Overall, the observed cross-reactivities were negligible in
comparison to the titer height of the antigens matching the
subtype of infection. Interestingly, we noted that heterologous
patterns largely reflected phylogenic relationships. The 16
currently known HA-types derived from birds divide into two
phylogenetic groups which further segregate into 5 clades. Group
1 consists of 3 clades (H1, H2, H5 and H6; H8, H9 and H12; H11,
H13 and H16) whereas group 2 comprises 2 clades (H3, H4 and
H14; H7, H10 and H15) [1,30]. Heterosubtypic immunity has
mainly been attributed to cytotoxic T-cells specific for internal
proteins [31], but neutralizing antibodies also play an important
role in protection [32,33]. To date, a number of broad reacting
intra-subtype-, intra-clade-, intra-group- and inter-group-specific
neutralizing monoclonal antibodies have been identified [34–37].
Figure 4. Antibody profiles of field chickens expressed as log2-transformed median antibody titer ratios plotted per outbreak.
Antibody titer ratios were derived by log transforming the data, calculating the median antibody reactivity across all antigens included on the PA and
subtracting it from the antibody reactivity against individual antigens. This was calculated for every chicken. By doing that, every individual’s values
are normalized according to its own background reactivity. Individual ratios were summarized in boxplots. Horizontal bars within each box represent
log2-transformed median antibody titer ratios per antigen and outbreak. Chickens naturally infected with H6 are depicted in red (n = 17), H7 in green
(n = 10) and H9 in blue (n = 8). The two H6-outbreaks were combined in this analysis.
doi:10.1371/journal.pone.0108043.g004
Table 3. Amino acid (AA) similarity matrix for strains of a particular subtype used to infect SPF chickens of group 2 (in bold) versus
PA-antigens per HA-type (table 1).
H5N2 100.00
H5.07 97.37 100.00
H5.02 96.15 96.42 100.00
H5.97 95.75 95.39 93.52 100.00
H5.06 95.29 95.45 94.21 97.48 100.00
H6N2 100.00
H6.07 96.01 100.00
H7N1 100
H7.03 97.11 100.00
H9N2 100.00
H9.99 97.49 100.00
H9.07 94.39 93.77 100.00
Similarity was calculated based on the HA1 part of the hemagglutinin (sequence length 318 AA). Percentages in bold and italics denote similarity between strains used
for infection versus corresponding PA-antigen.
doi:10.1371/journal.pone.0108043.t003
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Of all vaccination cohorts, H5-vaccinated chickens displayed the
highest level of cross-reactivity with antigen H2.05 (Figures 1, 2
and 3). This finding is not surprising due to the high sequence
similarity of these two subtypes [28,38]. Likewise, H9-positive
serum cross-reacted somewhat with members of the same clade,
H8 and H12. Together with the calculation of the median-log2-
titer ratios – as was performed for the field chickens in this study –,
the knowledge of these patterns can be useful in distinguishing
cross-reactivity from potential dual infections involving subtypes of
different clades. Although we only tested one serum of a chicken
simultaneously immunized with influenza virus strains belonging
to two different subtypes (H7 and H9), the PA showed clear
antibody titers against both HA-types (median log2-titer ratio for
H7.03= 8, H9.99= 6 and H9.07= 5.8, respectively) with no cross-
reactivity to other antigens (median log2-titer ratio = 0). This
capacity can be especially interesting for regions where AI
surveillance is not implemented in poultry and where animals
might experience multiple consecutive- or co-infections with
different subtypes. To further investigate this potential, serum of
experimentally infected chickens consecutively or simultaneously
immunized with different subtypes would need to be analyzed,
which were not available in this study.
Heterologous reaction was lowest in chickens experimentally
and naturally infected with subtype H7 compared to other serum
cohorts. This can possibly be explained by the fact that, apart from
H3- and H4-antigens, no other representatives of phylogenetic
group 2 (H10, H14, H15) were included in the PA setup.
Similarly, Latorre-Margaleff et al. [39] found that after infection
with a certain subtype, infection with the homologous- or subtypes
within the same clade and group were uncommon, suggesting
heterosubtypic immunity.
In this project, we showed that the PA can discriminate between
different HA-types. Strain-discrimination was not possible yet with
the PA, when more than one antigen per subtype was included,
e.g., H5. This intra-subtype reactivity is not unexpected since a
study found an intra-subtype similarity (based on AA-sequences of
the HA1) of .92%, whereas inter-subtype identity based on AA-
similarity was much lower (38.5%) [40]. Broad intra-subtype
reactivity is exploited in diagnostics. Ducatez et al. [41] discovered
that ancestral strain A of HP H5N1 as well as strains belonging to
clade 2.2 (represented by H5.06 in our study) proved to be the
most suitable antigen as they correctly identified most HP H5N1
antigens/-sera of other clades [41]. On the other hand, as genetic
changes can lead to escape mutants eliciting different serological
responses, it is important to monitor and regularly update the PA-
antigen setup, as is done for other serological assays [27]. The
extent to which strain discrimination can be achieved by means of
the PA is currently focus of a follow up project.
It is important to stress that the PA does not give information on
the presence or absence of neutralizing antibodies and can
therefore not be used to determine the immune status, i.e.
protection. In serological avian influenza surveillance the HI assay
is currently the gold standard with a sensitivity and specificity of
98.8% and 99.5%, respectively [42]. Overall, the PA showed a
good correlation with the HI test. Other currently known
serological multiplex techniques for the use in poultry, e.g. bead-
based Luminex assays, either target conserved regions of influenza
virus (nucleoprotein, matrix protein, non-structural protein 1)
[43], screen for antibodies against HA-types relevant for the
poultry sector (H5 and H7) [44] or combine the two approaches,
eg. nucleoprotein with H5 [45]. In addition, simultaneous
serological screening for influenza virus in combination with other
poultry diseases of economic importance (e.g., Newcastle Disease
Virus, Infectious Bronchitis Virus, Infectious Bursal Disease Virus)
are described in the literature [46,47]. To our knowledge, the PA
technique is the first to allow simultaneous detection of influenza
virus antibodies against more than two HA-types in chickens.
In this study, we aimed at including the full range of HA-types
known to be present in birds at the time. The dependence on
commercial availability lead to the random assembly of antigens of
Eurasian as well as North American lineages and failure to cover
all AIV subtypes. It is known that strains descending from
Eurasian and North American lineages of H5 and H7 differ
antigenically, as is reflected in differing titer heights in serological
assays [28]. Therefore, to achieve optimal results, the PA should
ideally comprise antigens relevant and topical for the region in
which the test is to be deployed. A limitation that should be
acknowledged is that the PA has only been tested with sera of
subtypes H5, H6, H7 and H9. To evaluate the performance
against other subtypes, additional serum cohorts would need to be
analyzed. Furthermore, the PA is limited to the detection of HA-
type specific antibodies and cannot identify antibodies against the
neuraminidase. It is not known as to what extent NA-specific
antibodies influence reactivities against the HA-proteins (due to
steric hindrance) in this testing platform [28].
In conclusion, we present a sensitive and specific test for the
simultaneous detection of HA-type specific antibodies against
different AIVs in chicken that requires very low amounts of serum.
In combination with a screening-ELISA targeting antibodies
against a conserved region of AIV, the PA can provide a valuable
epidemiological surveillance tool to monitor dispersal of different
subtypes. As this testing platform is also validated for the use in
humans [20,48] it lends itself for conducting exposure studies at
the human-animal interface. Current research centers on the
development of the PA for the use in swine.
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